TOKTY yields 56.98% · JNJ yields 2.13%● Live data
📍 TOKTY pulled ahead of the other in Year 1
Combined, TOKTY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TOKTY + JNJ for your $10,000?
Tokai Tokyo Financial Holdings, Inc. operates as a securities company in Japan. The company provides foreign equities, foreign bonds, structured bonds, and derivatives; investment trust services; and investment banking services, such as IPOs, public stock offerings, secondary sales, and mergers and acquisitions (M&A). Its activities also include financial instruments business; research on economic conditions and corporate performance; creation and management of funds, and self-financed investments; consulting on handling of testamentary trusts and inheritance property; asset management; fund investment; education and training; provision of transfer agency, merchandising, printing, real-estate rental management, and insurance agency services; and back-office operations. In addition, the company offers M&A, and cross-border advisory services; and investment management, advisory, and agency services. The company was formerly known as Tokai Tokyo Securities Co., Ltd. and changed its name to Tokai Tokyo Financial Holdings, Inc. in April 2009. Tokai Tokyo Financial Holdings, Inc. was incorporated in 1929 and is headquartered in Tokyo, Japan.
Full TOKTY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.